All Type of News
Hepatitis B market to be contested by 3 pharmaceutical firms
Pharmaceutical business sources that domestic hepatitis B market will emerge as an arena of tripartite competition GlaxoSmithKline's Zeffix (lamivudine) and Hepsera (adefovir), Bukwang Pharm's Levovir (clevudine) and...
Celltrion signs manufacturing agreement with Bristol-Myers Squibb Company
Celltrion announced on July 31 that it has completed an agreement with Bristol-Myers Squibb Company to manufacture biologic products being developed by Bristol-Myers Squibb.
In the bio-complex, Celltrion will initi...
Notice to our readers
Due to summer vacation English Yakup Daily will not publish August 3(Thursday), thru August 7(Monday), 2006.
We resume publication on August 8(Tuesday), 2006.
Government denies pressures from U.S. negotiators over new drug pricing and FTA talks
During the second round of negotiations for a proposed Korea-U.S. free trade agreement (FTA), there was no pressure from the United States on the Korean government to give up drug pricing reform or delay its introduct...
Pharmacy weighs business impact on non-NHI reimbursement of combined drug
Recently the government announced that 742 combined drugs turned to the non-NHI reimbursement schedule, for which the pharmacy circles took an attitude of a half positive with other half negative, expecting that in on...
Government to reinforce more fairness of tax collection system
The government has recently unveiled its plan to increasingly ensure fairness in the country's tax collection system by targeting high-income self-employed who tend to underreport their earnings.
To this end, the g...
New HIRA presient to stress policy based on evidences.
Mr. Kim Chang-yup who was named as the 4th new HIRA president, said in the inauguration ceremony at the auditorium on July 28 that the HIRA policy and project should be made on the basis of all evidences.
Preside...
KT to build new EDI network
KT was picked on July 26 as a preferred bidder to build a new electronic data interchange (EDI) network, according to the Health Insurance Review Agency and five medical/pharmaceutical organizations.
KT was picked ...
New drug policy worries multinationals
Multinational drug manufacturers are opposing the Korean government's plan to allow only cost-effective drugs to be covered by national health insurance.
Their reaction came out after the Ministry of Health and Wel...
Korea to cover cost-effective drugs
The Ministry of Health and Welfare said it will issue a pre-announcement on July 26, 60 days before changing the Korea's drug insurance policy, so that drugs approved by the ministry as better-priced and more effectiv...
